{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:07:34Z","timestamp":1784189254569,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To report the etiologies, antibiotic susceptibilities, and treatment outcomes of patients with culture-proven endophthalmitis associated with gram-negative organisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-center retrospective chart review of patients with positive vitreous cultures for gram-negative organisms who presented to a referral center from January 2014 to May 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 46 patients (mean age 69.5 years; 58.7% male). The most common isolates were\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (19\/46, 41.3%),\n                      <jats:italic>Haemophilus influenzae<\/jats:italic>\n                      (8\/46, 17.4%),\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (3\/46, 6.5%),\n                      <jats:italic>Morganella morganii<\/jats:italic>\n                      (3\/46, 6.5% and\n                      <jats:italic>Serratia marcescens<\/jats:italic>\n                      (3\/46, 6.5%). The most common etiologies were post-operative (20\/46, 43.5%), followed by bleb-associated (9\/46, 19.6%), corneal ulcer (6\/46, 13.0%), trauma (5\/46, 10.9%), endogenous (4\/46, 8.7%), and suture-related (2\/46, 4.3%). Most tested organisms were susceptible to amikacin (32\/34, 94.1%), gentamicin (33\/36, 91.7%), ceftazidime (36\/37, 97.3%), tobramycin (33\/35, 94.3%), and ciprofloxacin (34\/37, 91.9%). Lower susceptibility rates were observed for trimethoprim-sulfamethoxazole (12\/18, 66.7%) and ceftriaxone (13\/15, 86.7%). All tested organisms were susceptible to meropenem (30\/30, 100%). At the last follow-up, only 13.0% (6\/46) of patients had a visual acuity of 20\/800 or better, and 30.4% (14\/46) of patients had no light perception. Enucleation or evisceration was performed in 28.3% of patients (13\/46).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the current study, there were generally favorable susceptibilities to commonly used intravitreal antibiotics, but overall patients had poor visual outcomes regardless of specific causative organisms and etiologies. Despite appropriate treatment with intravitreal antibiotics and\/or pars plana vitrectomy, enucleation and evisceration were common.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-026-00597-8","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:25:53Z","timestamp":1779510353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endophthalmitis caused by gram-negative bacteria: etiologies, antibiotic susceptibilities, and treatment outcomes"],"prefix":"10.1186","volume":"16","author":[{"given":"Brandon","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry W.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"597_CR1","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/archopht.1995.01100120085015","volume":"113","author":"RK Forster","year":"1995","unstructured":"Forster RK (1995) The endophthalmitis vitrectomy study. Arch Ophthalmol 113:1555\u20131557","journal-title":"Arch Ophthalmol"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00417-014-2658-7","volume":"252","author":"A Gupta","year":"2014","unstructured":"Gupta A, Orlans HO, Hornby SJ, Bowler IC (2014) Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK. Graefes Arch Clin Exp Ophthalmol 252:1825\u20131830","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"597_CR3","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/bjophthalmol-2014-305030","volume":"98","author":"TP Moloney","year":"2014","unstructured":"Moloney TP, Park J (2014) Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review. Br J Ophthalmol 98:1492\u20131497","journal-title":"Br J Ophthalmol"},{"key":"597_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/02713683.2016.1188118","volume":"42","author":"C Liu","year":"2017","unstructured":"Liu C, Ji J, Li S, Wang Z, Tang L, Cao W et al (2017) Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases. Curr Eye Res 42:443\u2013447","journal-title":"Curr Eye Res"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajo.2013.01.027","volume":"156","author":"AM Schimel","year":"2013","unstructured":"Schimel AM, Miller D, Flynn HW Jr (2013) Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol 156:50\u201352e1","journal-title":"Am J Ophthalmol"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1442-9071.2008.01813.x","volume":"36","author":"JC Fan","year":"2008","unstructured":"Fan JC, Niederer RL, von Lany H, Polkinghorne PJ (2008) Infectious endophthalmitis: clinical features, management and visual outcomes. Clin Exp Ophthalmol 36:631\u2013636","journal-title":"Clin Exp Ophthalmol"},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ceo.12833","volume":"45","author":"VP Dave","year":"2017","unstructured":"Dave VP, Pathengay A, Nishant K, Pappuru RR, Sharma S, Sharma P et al (2017) Clinical presentations, risk factors and outcomes of ceftazidime-resistant Gram-negative endophthalmitis. Clin Exp Ophthalmol 45:254\u2013260","journal-title":"Clin Exp Ophthalmol"},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","volume":"121","author":"RC Gentile","year":"2014","unstructured":"Gentile RC, Shukla S, Shah M, Ritterband DC, Engelbert M, Davis A et al (2014) Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology 121:1634\u20131642","journal-title":"Ophthalmology"},{"key":"597_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IAE.0b013e3180323f96","volume":"27","author":"CA Lemley","year":"2007","unstructured":"Lemley CA, Han DP (2007) Endophthalmitis: a review of current evaluation and management. Retina 27:662\u2013680","journal-title":"Retina"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/00055735-200112000-00012","volume":"12","author":"SP Chee","year":"2001","unstructured":"Chee SP, Jap A (2001) Endogenous endophthalmitis. Curr Opin Ophthalmol 12:464\u2013470","journal-title":"Curr Opin Ophthalmol"},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0002-9394(14)70380-0","volume":"122","author":"Microbiologic factors","year":"1996","unstructured":"Microbiologic factors (1996) visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol 122:830\u2013846","journal-title":"Am J Ophthalmol"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1097\/IAE.0000000000000162","volume":"34","author":"J Sridhar","year":"2014","unstructured":"Sridhar J, Flynn HW Jr., Kuriyan AE, Dubovy S, Miller D (2014) Endophthalmitis caused by Klebsiella species. Retina 34:1875\u20131881","journal-title":"Retina"},{"key":"597_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/ceo.13768","volume":"48","author":"LJ Stevenson","year":"2020","unstructured":"Stevenson LJ, Dawkins RCH, Sheorey H, McGuinness MB, Hurley AH, Allen PJ (2020) Gram-negative endophthalmitis: A prospective study examining the microbiology, clinical associations and visual outcomes following infection. Clin Exp Ophthalmol 48:813\u2013820","journal-title":"Clin Exp Ophthalmol"},{"key":"597_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/ICB.0000000000000532","volume":"13","author":"BD Wilson","year":"2019","unstructured":"Wilson BD, Relhan N, Miller D, Flynn HW (2019) Jr. Gram-Negative Bacteria from Patients with Endophthalmitis: Distribution of Isolates and Antimicrobial Susceptibilities. Retin Cases Brief Rep 13:54\u201356","journal-title":"Retin Cases Brief Rep"},{"key":"597_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/IAE.0000000000001603","volume":"37","author":"N Relhan","year":"2017","unstructured":"Relhan N, Pathengay A, Schwartz SG, Flynn HW (2017) Jr. Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. Retina 37:811\u2013818","journal-title":"Retina"},{"key":"597_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/bjo.2004.054007","volume":"89","author":"V Vedantham","year":"2005","unstructured":"Vedantham V (2005) Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin! Br J Ophthalmol 89:249\u2013250","journal-title":"Br J Ophthalmol"},{"key":"597_CR17","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2147\/OPTH.S67894","volume":"8","author":"S Sanghi","year":"2014","unstructured":"Sanghi S, Pathengay A, Jindal A, Raval V, Nayak S, Sharma S et al (2014) Acute-onset postoperative endophthalmitis caused by multidrug-resistant Klebsiella pneumoniae. Clin Ophthalmol 8:1783\u20131785","journal-title":"Clin Ophthalmol"},{"key":"597_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/nyas.13672","volume":"1435","author":"SE Hawken","year":"2019","unstructured":"Hawken SE, Snitkin ES (2019) Genomic epidemiology of multidrug-resistant Gram-negative organisms. Ann N Y Acad Sci 1435:39\u201356","journal-title":"Ann N Y Acad Sci"},{"key":"597_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15585\/mmwr.mm6601a7","volume":"66","author":"L Chen","year":"2017","unstructured":"Chen L, Todd R, Kiehlbauch J, Walters M, Kallen A (2017) Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016. MMWR Morb Mortal Wkly Rep 66:33","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"597_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1473-3099(05)70086-4","volume":"5","author":"SR Norrby","year":"2005","unstructured":"Norrby SR, Nord CE, Finch R, European Society of Clinical Microbiology Infectious Diseases (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5:115\u2013119","journal-title":"Lancet Infect Dis"},{"key":"597_CR21","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther 40:277\u2013283","journal-title":"Pharm Ther"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-026-00597-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00597-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00597-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:39:44Z","timestamp":1784187584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-026-00597-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1186\/s12348-026-00597-8","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was reviewed and approved by the University of Miami Institutional Review Board, approval number 20120897. This study involved retrospective review of medical records, and a waiver of consent was obtained from the University of Miami Institutional Review Board. This research was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of de-identified clinical images was collected for all patients through institutional consent forms.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"35"}}